Impetigo: Bacterial Skin Infections: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Folliculitis, Skin Abscesses, and Carbuncles: Bacterial Skin Infections: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Staphylococcal Infections: Bacterial Infections: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Teva Pharmaceutical Industries - News and PR - - Search Tevapharm: - - Press Release Teva Announces Approval Of Mupirocin Ointment Jerusalem, Israel, November 9, 2003 - Teva Pharmaceutical Industries Ltd.Mupirocin Ointment USP, 2%.Mupirocin Ointment USP, 2% is the AB-rated generic equivalent of GlaxoSmithKline’s Bactroban &...
Drug Approvals - B Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted Bacitracin Injection, 50,000 units/vial, Rx American Pharmaceutical Partners ANDA 65-116 12/3/02 - - - Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP, Rx Altana, Inc
http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
1999 Warning Letters and Untitled Letters to Pharmaceutical Companies Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 1999 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information OfficeBactroban ...
Prescription and Over-the-Counter Drug Product List: 11/2003 ACTHAR GEL >D> BC + QUESTCOR PHARMS 80 UNITS/ML N08372 008 NOV CTEC >A> + 80 UNITS/ML N08372 008 NOV CTEC CYTARABINE INJECTABLE; INJECTION >D> CYTARABINE >D> AP + GENSIA SICOR PHARMS 100MG/VIAL N16793 001 NOV DISC >D> AP + 500MG/VIAL N16793 002 NOV DISC >D> AP + 1GM/VIAL N16793 003 DEC 21, 1987 NOV DISC >D> AP + 2GM/VIAL N16793 004 DEC 21, 1987 NOV DISC >A> @ SICOR PHARMS 100MG/VIAL...
Microsoft Word - Medication_Listing.doc page 32
author: Wendy Daws
Microsoft Word - Master_Index.doc S.®) 14 28: 08.08 morphine sulfate sustained release (MS Contin®, M- Eslon®) Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 14 28: 08.08 morphine sulphate 14 28: 08.08 Motilium® 28 56: 40 Motrin® 16 28: 08.04 MS Contin® Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 01) 14 28: 08.08 multivitamin 36 88: 28...
author: Wendy Daws
Microsoft Word - Master_Index.doc page 33
author: Wendy Daws
Microsoft Word - Master_Index.doc page 4
author: Wendy Daws
Microsoft Word - Master_Index.doc S.®) 14 28: 08.08 morphine sulfate sustained release (MS Contin®, M- Eslon®) Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 14 28: 08.08 morphine 14 28: 08.08 Motilium® 28 56: 40 Motrin® 16 28: 08.04 MS Contin® Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 01) 14 28: 08.08 multivitamin 36 88: 28 multivitamin...
author: Wendy Daws
CONCEPTS FOR CARE 1 65059
author: Information Services
CONCEPTS FOR CARE page 2
author: Information Services
Current Management of Common Skin and Soft Tissue Infections: Year 2001 Update Trouble navigating this siteMupirocin 2% ointment (Bactroban ®) is applied three times dailyMupirocin 2% ointment in a calcium base (Bactroban ® Nasal Ointment) applied twice daily for five days will usually cure this problem
4:00 page 27
author: Christine Wildman
4:00 page 32
author: Christine Wildman
FDA Drug Approvals List- April 1999 Original Application #: 050760 Approval Date: 15-APR-99 Trade Name: AMOXIL Chemical Type: 3 Therapeutic Potential: S Dosage Form: SUSPENSION Applicant: SMITHKLINE BEECHAM PHARMACEUTICALS Active Ingredient(s): AMOXICILLIN OTC/RX Status: RX Indication(s):For the use of Amoxil for oral suspension 200mg/5mL and 400mg/5mL in divided doses q12h Original Application #: 020924 Approval Date:...
50591S22 page 1
author: Unknown
DDPA September 1995 DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE NDA NUMBER TRADE NAME APPLICANT ACTIVE INGREDIENT(S) APPROVAL DATE (DOSAGE FORM) STRENGTH(S) (CLASSIFICATION) CLASSIFICATION(S) ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 16-968 MIOSTAT ALCON LABS CARBACHOL 18-AUG-95 (SOLUTION) FORT WORTH, TX 0.01% (SUPPL-013) 76134 (NEW INDICATION -- TO REDUCE THE...
DDPA February 1996 THERE ARE NO ORIGINAL ABBREVIATED AND 505(b)(2) NDAs WITH TENTATIVE APPROVALS FOR FEBRUARY 1996 ***LABELING SUPPLEMENTS TO ORIGINAL NDAs*** 20-123 OMNIS CAN NYCOMED GADODIAMIDE 05-FEB-96 (INJECTABLE) WAYNE, PA 287MG/ML 19087 (LABELING REVISION -- INDICATIONS AND USAGE; DOSAGE AND ADMINISTRATION) 19-099 DOPAMINE HCL AND MCGAW DOPAMINE HYDROCHLORIDE 07-FEB-96 DEXTROSE 5% IRVINE, CA...
Drug Approvals for December 1997 Active Ingredient(s): EMEDASTINE DIFUMARATE OTC/RX Status: RX Indication(s): For the temporary relief of the signs and symptoms of allergic conjunctivitis Original Application #: 020786 Approval Date: 24-DEC-97 Trade Name: ALLEGRA-D Chemical Type: 4 Therapeutic Potential: S Dosage Form: TABLET, EXTENDED RELEASE Applicant: HOECHST MARION ROUSSEL, INC Active Ingredient(s): FEXOFENADINE...
GlaxoSmithKline - Do more, feel better, live longer Jump to navigation Jump to footer Do more, feel better.
author: Corporate Comms
Derma Sciences - Clinical and Scientific Data - Zinc-Saline Wet Dressings and Normal Saline Wet Dressings in the Management of Search --|-- Contact Us -.awmAnchor {position:relative;z-index:0} - Clinical & Scientific Data Zinc-Saline Wet Dressings and Normal Saline Wet Dressings in the Management of Lower Extremity Ulcerations Dr.
